EP3801552A4 - Composition et procédé d'inhalation - Google Patents

Composition et procédé d'inhalation Download PDF

Info

Publication number
EP3801552A4
EP3801552A4 EP19815062.5A EP19815062A EP3801552A4 EP 3801552 A4 EP3801552 A4 EP 3801552A4 EP 19815062 A EP19815062 A EP 19815062A EP 3801552 A4 EP3801552 A4 EP 3801552A4
Authority
EP
European Patent Office
Prior art keywords
inhalation
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19815062.5A
Other languages
German (de)
English (en)
Other versions
EP3801552A1 (fr
Inventor
Joseph J. Guarneri
Nikhil AMIN
Marshall L. Grant
John J. Freeman
Kelly S. Kraft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mannkind Corp
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of EP3801552A1 publication Critical patent/EP3801552A1/fr
Publication of EP3801552A4 publication Critical patent/EP3801552A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP19815062.5A 2018-06-07 2019-06-07 Composition et procédé d'inhalation Pending EP3801552A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862682109P 2018-06-07 2018-06-07
PCT/US2019/036095 WO2019237028A1 (fr) 2018-06-07 2019-06-07 Composition et procédé d'inhalation

Publications (2)

Publication Number Publication Date
EP3801552A1 EP3801552A1 (fr) 2021-04-14
EP3801552A4 true EP3801552A4 (fr) 2022-02-23

Family

ID=68770678

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19815062.5A Pending EP3801552A4 (fr) 2018-06-07 2019-06-07 Composition et procédé d'inhalation

Country Status (5)

Country Link
EP (1) EP3801552A4 (fr)
JP (1) JP2021527058A (fr)
AU (2) AU2019282808B2 (fr)
CA (1) CA3102967A1 (fr)
WO (1) WO2019237028A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3060041T3 (pl) 2013-10-25 2021-08-02 Insmed Incorporated Związki prostacykliny
IL319790A (en) 2016-05-05 2025-05-01 Liquidia Tech Inc Terpostinil in dry powder form for the treatment of pulmonary hypertension
JP7455144B2 (ja) 2019-04-29 2024-03-25 インスメッド インコーポレイテッド トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法
US11826327B2 (en) 2020-04-17 2023-11-28 United Therapeutics Corporation Treatment for interstitial lung disease
KR20250057075A (ko) 2020-06-09 2025-04-28 유나이티드 쎄러퓨틱스 코포레이션 트레프로스티닐의 푸마릴 디케토피페리딘 프로드러그
WO2022094100A1 (fr) * 2020-10-28 2022-05-05 Insmed Incorporated Compositions de poudre sèche de promédicaments de tréprostinil et procédés d'utilisation associés
US20220152025A1 (en) 2020-11-17 2022-05-19 United Therapeutics Corporation Inhaled imatinib for pulmonary hypertension
IL303431A (en) * 2020-12-07 2023-08-01 Mannkind Corp Method and composition for the treatment of pulmonary fibrosis
EP4301372A1 (fr) * 2021-03-03 2024-01-10 United Therapeutics Corporation Composition de poudre sèche de treprostinil et son promédicament et comprenant en outre de l'(e)-3,6-bis[4-(n-carbonyl-2-propényl)amidobutyl]-2,5-dicétopipérazine (fdkp)
CN118201602A (zh) * 2021-10-27 2024-06-14 曼金德公司 用于治疗肺高压的方法和组合物
JP2025506019A (ja) 2022-02-08 2025-03-05 ユナイテッド セラピューティクス コーポレイション トレプロスチニルイロプロスト併用療法
WO2025160403A1 (fr) * 2024-01-24 2025-07-31 Mannkind Corporation Système de transport de poudre

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140199398A1 (en) * 2011-06-17 2014-07-17 Mannkind Corporation High capacity diektopiperazine microparticles and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
KR101486397B1 (ko) * 2005-09-14 2015-01-28 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
KR102246914B1 (ko) * 2013-03-15 2021-04-30 맨카인드 코포레이션 미세결정성 디케토피페라진 조성물 및 방법
JP2019504684A (ja) * 2016-01-29 2019-02-21 マンカインド コーポレイション 乾燥粉末吸入器
IL319790A (en) * 2016-05-05 2025-05-01 Liquidia Tech Inc Terpostinil in dry powder form for the treatment of pulmonary hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140199398A1 (en) * 2011-06-17 2014-07-17 Mannkind Corporation High capacity diektopiperazine microparticles and methods

Also Published As

Publication number Publication date
JP2021527058A (ja) 2021-10-11
AU2019282808A1 (en) 2021-01-07
WO2019237028A1 (fr) 2019-12-12
AU2025202053A1 (en) 2025-04-10
AU2019282808B2 (en) 2025-03-20
EP3801552A1 (fr) 2021-04-14
CA3102967A1 (fr) 2019-12-12

Similar Documents

Publication Publication Date Title
EP3801552A4 (fr) Composition et procédé d'inhalation
EP3850088A4 (fr) Compositions et procédés d'amélioration de l'édition de base
EP3866924A4 (fr) Compositions et procédés d'administration d'anticorps
EP3490622C0 (fr) Méthodes et compositions utilisées pour la cicatrisation
EP3704254A4 (fr) Compositions de cas12c et procédés d'utilisation
EP3844553C0 (fr) Procédé et système d'estimation du regard
EP3445251A4 (fr) Dispositifs de biopsie et leurs procédés d'utilisation
EP3551033A4 (fr) Endoscope et procédé d'utilisation
EP3478723A4 (fr) Anticorps spécifiques de pd-l1 et procédés pour les utiliser
EP3484469A4 (fr) Compositions et procédés de potentialisation d'agents antimicrobiens
EP3599854A4 (fr) Pyrrolidinones et procédé pour les préparer
EP3558502A4 (fr) Membrane d'osmose inverse et procédé de fabrication
EP3558303A4 (fr) Composés acides aminés et leurs procédés d'utilisation
EP3803403A4 (fr) Compositions et procédés d'imagerie
EP3720378C0 (fr) Cathéter et procédé d'assemblage de cathéter
EP3534710A4 (fr) Compositions d'enrobage et leurs procédés d'utilisation
EP3733650C0 (fr) Procédé de préparation d'un intermédiaire d'élagolix et composition associée
EP3796894A4 (fr) Procédés et compositions pour l'édition génomique
DE112018000901A5 (de) Verfahren und Vorrichtung zur Beatmung
EP3710588A4 (fr) Compositions et méthodes pour inhiber l'expression de l'aldh2
EP3851466A4 (fr) Polyoxyméthylène et son procédé de production
EP3506982A4 (fr) Inhibiteurs de mif et leurs méthodes d'utilisation
EP3687628A4 (fr) Compositions et méthodes pour inhiber acss2
EP3579966C0 (fr) Composition de sorbant et méthode de fabrication
EP3416536C0 (fr) Guide de type winguide et son procédé d'utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40049543

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20220124

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 15/00 20060101ALI20220118BHEP

Ipc: A61K 31/5575 20060101ALI20220118BHEP

Ipc: A61K 9/16 20060101ALI20220118BHEP

Ipc: A61K 9/48 20060101ALI20220118BHEP

Ipc: A61K 9/00 20060101ALI20220118BHEP

Ipc: A61K 31/557 20060101AFI20220118BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230506

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240131